Ovarian Tissue Freezing For Fertility Preservation

Status Recruiting

Clinical Trial Summary

The purpose of this study is to offer an alternative method to women who wish to preserve the possibility of fertility, as well as to learn more about the ability of human eggs to survive and function after long term storage in frozen ovaries (ovarian tissue cryopreservation). The study will seek to preserve ovarian tissue and reproductive potential for patients whose medical or surgical treatment may harm ovaries or remove ovarian tissue.

Clinical Trial Description

Women who have not yet undergone this procedure, and who present to the Fertility Consultants desiring fertility preservation, will be offered participation in the study. Subjects will undergo an initial visit which will include a blood draw, ultrasound, and any additional tests or exams that are medically indicated for the subject's diagnosis in preparation for surgery. Subjects will then undergo an oophorectomy surgery (removal of one or both ovaries). Following removal, subject's ovarian tissue will be cryopreserved (frozen) and stored for possible future use. We also plan to collect subjects medical history information to enter into a research database. Subjects will be followed until they decide to use their tissue for fertility purposes. We will also retrospectively enroll women who have already undergone this procedure by contacting them by mail and offering participation in our ovarian tissue cryopreservation database. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00902720
Study type	Interventional
Source	Oregon Health and Science University
Contact	David M Lee, MD
Phone	503-418-3700
Email	leedavi@ohsu.edu
Status	Recruiting
Phase	Phase 4
Start date	May 2009
Completion date	March 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05640115` - Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent	Early Phase 1
Recruiting	`NCT02891642` - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Completed	`NCT02282449` - Power Injectable Versus a Non-Power Injectable, Upper Arm, TIVAD for Chemotherapy	N/A
Completed	`NCT01212731` - Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
Completed	`NCT01199822` - Study of the Safety and Pharmacokinetics of IMC-3G3 in Japanese Patients With Solid Tumors	Phase 1
Recruiting	`NCT04122469` - The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease	N/A
Recruiting	`NCT03561727` - Risk Factors for Development of Incisional Hernia in Transverse Incisions	N/A
Terminated	`NCT03251924` - A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT03997968` - A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT00092222` - Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity	Phase 2
Recruiting	`NCT05770102` - DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition	Phase 2/Phase 3
Recruiting	`NCT05886764` - Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials	N/A
Not yet recruiting	`NCT05992363` - Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction	Phase 3
Recruiting	`NCT05761366` - Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor	Phase 2
Recruiting	`NCT04887545` - Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients
Completed	`NCT03061955` - Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Completed	`NCT03909464` - Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
Active, not recruiting	`NCT02649491` - Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy	N/A
Recruiting	`NCT02776995` - Tumor Monitoring Using Thermography During Radiation Therapy	N/A
Active, not recruiting	`NCT01242072` - Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies	Phase 1